My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 90

    1.

    Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients.

    Stettler C, Stahl M, Allemann S, Diem P, Schmidlin K, Zwahlen M, Riesen W, Keller U, Christ E.

    Diabetes Care. 2008 Aug;31(8):1534-5. Epub 2008 Apr 21.PMID: 18426859 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.

    Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S.

    Diabetes Care. 2006 Jun;29(6):1214-9.PMID: 16731998 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.

    Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, Akaoka L, Miyashita H.

    Lancet. 1996 Jun 1;347(9014):1514-8.PMID: 8684103 [PubMed - indexed for MEDLINE]Related articles

    4.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    5.

    Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.

    Feinglos MN, Thacker CH, English J, Bethel MA, Lane JD.

    Diabetes Care. 1997 Oct;20(10):1539-42.PMID: 9314631 [PubMed - indexed for MEDLINE]Related articles

    6.

    Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

    Bastyr EJ 3rd, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE.

    Diabetes Care. 2000 Sep;23(9):1236-41.PMID: 10977012 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions.

    Trovati M, Ponziani MC, Massucco P, Anfossi G, Mularoni EM, Burzacca S, Tassone F, Perna P, Traversa M, Cavalot F.

    Eur J Clin Invest. 2002 Mar;32(3):179-86.PMID: 11895469 [PubMed - indexed for MEDLINE]Related articles

    8.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    9.

    Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.

    Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M.

    J Clin Endocrinol Metab. 2006 Mar;91(3):813-9. Epub 2005 Dec 13.PMID: 16352690 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

    Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

    Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

    Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ.

    Diabetes Care. 2009 Mar;32(3):381-6.PMID: 19246588 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients: response to Stettler et al.

    Schindhelm RK, Diamant M, Bilo HJ, Slingerland RJ.

    Diabetes Care. 2008 Nov;31(11):e89; author reply e90. No abstract available. Erratum in: Diabetes Care. 2009 Jan;32(1):207. PMID: 18955716 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).

    Gribble FM, Manley SE, Levy JC.

    Diabetes Care. 2001 Jul;24(7):1221-5.PMID: 11423506 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.

    Frias JP, Yu JG, Kruszynska YT, Olefsky JM.

    Diabetes Care. 2000 Jan;23(1):64-9.PMID: 10857970 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

    Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B.

    Diabetes Res Clin Pract. 2007 Aug;77(2):280-5. Epub 2007 Jan 22.PMID: 17240473 [PubMed - indexed for MEDLINE]Related articles

    16.

    Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

    Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

    Diabetes Care. 2003 Feb;26(2):421-6.PMID: 12547873 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A study of forearm versus finger stick glucose monitoring.

    Lee DM, Weinert SE, Miller EE.

    Diabetes Technol Ther. 2002;4(1):13-23; discussion 45-7.PMID: 12017415 [PubMed - indexed for MEDLINE]Related articles

    18.

    Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.

    Yamanouchi T, Kawasaki T, Yoshimura T, Inoue T, Koshibu E, Ogata N, Funato H, Akaoka I, Miyashita H.

    Diabetes Care. 1998 Apr;21(4):619-24.PMID: 9571353 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

    Monnier L, Colette C, Dunseath GJ, Owens DR.

    Diabetes Care. 2007 Feb;30(2):263-9.PMID: 17259492 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.

    Kishimoto M, Yamasaki Y, Kubota M, Arai K, Morishima T, Kawamori R, Kamada T.

    Diabetes Care. 1995 Aug;18(8):1156-9.PMID: 7587851 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity